Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
Authors:
- J L UrbanJUJ L Urban
- H M ShepardHSH M Shepard
- J L RothsteinJRJ L Rothstein
- B J SugarmanBSB J Sugarman
- H SchreiberHSH Schreiber
- 1 July 1986
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 83 (14) , 5233-5237
Abstract
Activated macrophages (aM phi) destroy more effectively cancer cells than normal cells. The mechanism by which macrophages destroy cancer cells is not known. We report here that tumor cells susceptible to aM phi were killed by recombinant (r) tumor necrosis factor type alpha (TNF-alpha), whereas variant tumor cells resistant to aM phi after selection in vitro or in vivo were resistant to killing by rTNF-alpha. The converse selection for rTNF-alpha-resistant variants resulted in cells that were also resistant to killing by aM phi. The sensitivity of macrophage-resistant variants was not changed to other tumoricidal cells or soluble mediators, except that the macrophage-resistant variants were also resistant to the effects of another cytotoxic protein, B-cell lymphotoxin, which is structurally related to rTNF-alpha. Similar results were obtained regardless of whether short-term or long-term cytotoxic effects of aM phi were measured. Finally, it was shown that killing of tumor cells by murine aM phi was completely inhibited with a polyclonal antibody that neutralizes the effects of murine TNF-alpha. These results suggest a major role for TNF-alpha in tumor cell destruction by aM phi in vitro and in vivo.Keywords
This publication has 29 references indexed in Scilit:
- High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.Journal of Experimental Medicine, 1985
- Cloning and expression in Escherichia coli of the gene for human tumour necrosis factorNature, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityNature, 1984
- Cloning and expression of murine interleukin-1 cDNA in Escherichia coliNature, 1984
- Multiple tumour-specific antigens expressed on a single tumour cellNature, 1983
- Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.Journal of Experimental Medicine, 1982
- Control of Carcinogenesis: A Possible Role for the Activated MacrophageScience, 1972
- The in vitro induction and release of a cell toxin by immune C57B1/6 mouse peritoneal macrophagesCellular Immunology, 1972
- ALTERATIONS OF MACROPHAGE FUNCTIONS BY MEDIATORS FROM LYMPHOCYTESJournal of Experimental Medicine, 1971